Literature DB >> 15099023

Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers.

Thomas G Beach1, Douglas G Walker, Lucia I Sue, Amanda Newell, Charles C Adler, Jeffrey N Joyce.   

Abstract

Marinesco bodies are nuclear inclusions found in pigmented neurons of the substantia nigra and locus ceruleus of humans and monkeys. It has long been known that the frequency of these inclusions increases with advancing age, but no pathologic associations have ever been established. We quantified Marinesco body frequency in human autopsy subjects, classified as young normal controls, elderly controls, dementia with Lewy bodies (DLB), Alzheimer disease (AD), and Parkinson disease (PD). Elderly controls, AD cases, and DLB cases had significantly increased Marinesco body frequencies relative to young controls and DLB cases had significantly increased frequencies relative to elderly controls, while PD cases did not differ from young controls; cases with AD did not differ from elderly controls. Lewy body-containing neurons had significantly higher Marinesco body frequencies than non-Lewy body-containing neurons. Marinesco body frequency in elderly control cases correlated significantly, in inverse fashion, with striatal concentrations of the dopaminergic neuron markers dopamine transporter and tyrosine hydroxylase. These statistical associations suggest that Marinesco bodies constitute or mark a pathologic process that may be related to, or contribute to, age-related motor dysfunction and/or Lewy body disorders. Further studies are needed to ascertain the molecular basis of Marinesco body formation; preliminary studies indicate that proteasome dysfunction can lead to similar abnormalities in cultured cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15099023     DOI: 10.1093/jnen/63.4.329

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  20 in total

1.  G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies.

Authors:  Carles Gaig; María José Martí; Mario Ezquerra; Adriana Cardozo; Maria Jesus Rey; Eduardo Tolosa
Journal:  BMJ Case Rep       Date:  2009-01-23

2.  G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies.

Authors:  Carles Gaig; María José Martí; Mario Ezquerra; Maria Jesús Rey; Adriana Cardozo; Eduardo Tolosa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-08       Impact factor: 10.154

3.  Marinesco bodies and substantia nigra neuron density in Parkinson's disease.

Authors:  R D Abbott; J S Nelson; G W Ross; J H Uyehara-Lock; C M Tanner; K H Masaki; L J Launer; L R White; H Petrovitch
Journal:  Neuropathol Appl Neurobiol       Date:  2017-07-09       Impact factor: 8.090

Review 4.  Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates.

Authors:  Timothy J Collier; Nicholas M Kanaan; Jeffrey H Kordower
Journal:  Nat Rev Neurosci       Date:  2011-05-18       Impact factor: 34.870

5.  Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.

Authors:  Thomas G Beach; Charles H Adler; Lucia I Sue; Geidy Serrano; Holly A Shill; Douglas G Walker; LihFen Lue; Alex E Roher; Brittany N Dugger; Chera Maarouf; Alex C Birdsill; Anthony Intorcia; Megan Saxon-Labelle; Joel Pullen; Alexander Scroggins; Jessica Filon; Sarah Scott; Brittany Hoffman; Angelica Garcia; John N Caviness; Joseph G Hentz; Erika Driver-Dunckley; Sandra A Jacobson; Kathryn J Davis; Christine M Belden; Kathy E Long; Michael Malek-Ahmadi; Jessica J Powell; Lisa D Gale; Lisa R Nicholson; Richard J Caselli; Bryan K Woodruff; Steven Z Rapscak; Geoffrey L Ahern; Jiong Shi; Anna D Burke; Eric M Reiman; Marwan N Sabbagh
Journal:  Neuropathology       Date:  2015-01-26       Impact factor: 1.906

6.  Genetic neuropathology of Parkinson's disease.

Authors:  Mark R Cookson; John Hardy; Patrick A Lewis
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

7.  Neuropathology and Cellular Pathogenesis of Spinocerebellar Ataxia Type 12.

Authors:  Elizabeth E O'Hearn; Hyon S Hwang; Susan E Holmes; Dobrila D Rudnicki; Daniel W Chung; Ana I Seixas; Rachael L Cohen; Christopher A Ross; John Q Trojanowski; Olga Pletnikova; Juan C Troncoso; Russell L Margolis
Journal:  Mov Disord       Date:  2015-09-04       Impact factor: 10.338

Review 8.  A critical evaluation of the ubiquitin-proteasome system in Parkinson's disease.

Authors:  Casey Cook; Leonard Petrucelli
Journal:  Biochim Biophys Acta       Date:  2009-02-03

9.  Neuropathology of cervical dystonia.

Authors:  C N Prudente; C A Pardo; J Xiao; J Hanfelt; E J Hess; M S Ledoux; H A Jinnah
Journal:  Exp Neurol       Date:  2012-11-27       Impact factor: 5.330

Review 10.  The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism.

Authors:  Hemant Kumar; Hyung-Woo Lim; Sandeep Vasant More; Byung-Wook Kim; Sushruta Koppula; In Su Kim; Dong-Kug Choi
Journal:  Int J Mol Sci       Date:  2012-08-21       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.